- Home
- INTZ vs IGC Comparison
INTZ vs IGC Comparison
Compare INTZ & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTZ
- IGC
- Stock Information
- Founded
- INTZ 1983
- IGC 2005
- Country
- INTZ United States
- IGC United States
- Employees
- INTZ N/A
- IGC N/A
- Industry
- INTZ Computer Communications Equipment
- IGC Biotechnology: Pharmaceutical Preparations
- Sector
- INTZ Telecommunications
- IGC Health Care
- Exchange
- INTZ Nasdaq
- IGC Nasdaq
- Market Cap
- INTZ 33.8M
- IGC 33.5M
- IPO Year
- INTZ 2020
- IGC N/A
- Fundamental
- Price
- INTZ $1.79
- IGC $0.37
- Analyst Decision
- INTZ Buy
- IGC Strong Buy
- Analyst Count
- INTZ 2
- IGC 2
- Target Price
- INTZ $6.75
- IGC $3.88
- AVG Volume (30 Days)
- INTZ 350.8K
- IGC 862.4K
- Earning Date
- INTZ 08-12-2025
- IGC 08-14-2025
- Dividend Yield
- INTZ N/A
- IGC N/A
- EPS Growth
- INTZ N/A
- IGC N/A
- EPS
- INTZ N/A
- IGC N/A
- Revenue
- INTZ $6,828,000.00
- IGC $1,327,000.00
- Revenue This Year
- INTZ $35.18
- IGC $15.26
- Revenue Next Year
- INTZ $32.43
- IGC $3.41
- P/E Ratio
- INTZ N/A
- IGC N/A
- Revenue Growth
- INTZ 25.86
- IGC 24.95
- 52 Week Low
- INTZ $0.35
- IGC $0.25
- 52 Week High
- INTZ $7.34
- IGC $0.48
- Technical
- Relative Strength Index (RSI)
- INTZ 44.19
- IGC 57.43
- Support Level
- INTZ $1.58
- IGC $0.35
- Resistance Level
- INTZ $2.08
- IGC $0.37
- Average True Range (ATR)
- INTZ 0.17
- IGC 0.02
- MACD
- INTZ 0.01
- IGC -0.00
- Stochastic Oscillator
- INTZ 28.77
- IGC 79.80
About INTZ Intrusion Inc.
Intrusion Inc is a cybersecurity company based in Plano, Texas. The group offers customers to access its threat intelligence database containing the historical data, known associations, and reputational behavior of Internet Protocol (IP) addresses. The company's product consists of On-Premise Network Protection, Cyber Threat Consulting, Cloud Network Security, and Endpoint Protection. Its solutions are INTRUSION Shield, INTRUSION TraceCop, and INTRUSION Savant. Its end-user customers include the U.S. federal government, state and local government entities, large and diversified conglomerates, and manufacturing entities.
About IGC IGC Pharma Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.